Thromboxane A2 (TXA2) receptor antagonist improves exercise tolerance in patients with COPD

被引:0
|
作者
Inoue, T
Mori, M
Matsubara, H
Oguma, T
Okubo, Y
Shiomi, T
Tateno, H
Meguro, Y
Yamaguchi, K
机构
[1] Keio Univ, Sch Med, Dept Med, Tokyo, Japan
[2] Keio Univ, Sch Med, Hlth Management Ctr, Tokyo, Japan
关键词
D O I
暂无
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
引用
收藏
页码:A802 / A802
页数:1
相关论文
共 50 条
  • [41] Diversity of signaling underlying responses mediated by selective activation of the platelet thromboxane A2 (TXA2) receptor;: pharmacological and kinetic studies in vitro
    Maayani, S
    Schwarz, TE
    Patel, ND
    Craddock-Royal, BD
    Tagliente, TM
    PLATELETS, 2003, 14 (06) : 359 - 374
  • [42] Effects of cysteinyl-leukotriene receptor antagonist, thromboxane A2 receptor antagonist, and thromboxane A2 synthetase inhibitor on antigen-induced bronchoconstriction in patients with asthma
    Obase, Y
    Shimoda, T
    Matsuo, N
    Matsuse, H
    Asai, S
    Kohno, S
    CHEST, 1998, 114 (04) : 1028 - 1032
  • [43] The Effects of AT1 Receptor Blockade on Skin Microcirculatory Blood Flow and Thromboxane A2 (TXA2) Production in Young Healthy Women
    Cavka, Ana
    Grizelj, Ivana
    Cosic, Anita
    Koller, Akos
    Jelakovic, Bojan
    Lombard, Julian H.
    Phillips, Shane A.
    Drenjancevic, Ines
    FASEB JOURNAL, 2013, 27
  • [44] SYNTHESIS OF A THROMBOXANE-A(2) RECEPTOR ANTAGONIST POSSESSING THE DIOXABICYCLOHEPTANE NUCLEUS OF TXA(2)
    PREMCHANDRAN, RH
    OGLETREE, ML
    FRIED, J
    JOURNAL OF ORGANIC CHEMISTRY, 1993, 58 (21): : 5724 - 5731
  • [45] Agonist affinity changes of the thromboxane (TXA2) receptor:: The role of Gα13.
    Kaldas, MI
    Halushka, PV
    FASEB JOURNAL, 2001, 15 (05): : A931 - A931
  • [46] CGS-23305 - INVITRO CHARACTERIZATION OF A POTENT THROMBOXANE-A PROSTAGLANDIN-H (TXA2 PGH2) RECEPTOR ANTAGONIST AND THROMBOXANE SYNTHASE INHIBITOR
    DOTSON, R
    COHEN, D
    MATHIS, J
    FURNESS, P
    LEE, W
    BHAGWAT, S
    GUDE, C
    FASEB JOURNAL, 1992, 6 (04): : A1599 - A1599
  • [47] The presence of the TXA2 receptor in lipid rafts of platelets is necessary for platelet activation by TXA2
    Moscardo, Antonio
    Valles, Juana
    Madrid, Isabel
    Latorre, Ana
    Dasi, Angeles
    Teresa Santos, Maria
    THROMBOSIS RESEARCH, 2012, 130 : S103 - S103
  • [48] Soluble dipeptidyl peptidase 4 triggers endothelial cell senescence: which role for thromboxane A2 (TXA2)?
    Valencia, Ines
    Romero, Alejandra
    San Hipolito, Alvaro
    Dongil, Pilar
    Carraro, Rafaelle
    Romacho, Tania
    Peiro, Concepcion
    Sanchez Ferrer, Carlos Felix
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2019, 125 : 32 - 33
  • [49] TICLOPIDINE BUT NOT A SPECIFIC THROMBOXANE-A2 (TXA2) RECEPTOR ANTAGONIST RETARDS RENAL-DISEASE PROGRESSION IN RATS WITH REDUCED RENAL MASS
    MORIGI, M
    ZOJA, C
    PERICO, N
    DADAN, J
    BERTANI, T
    REMUZZI, G
    KIDNEY INTERNATIONAL, 1990, 37 (01) : 424 - 424
  • [50] CONTENT OF PROSTACYCLINE (PGI2) AND THROMBOXANE-A2 (TXA2) IN PLASMA OF PATIENTS WITH PSORIASIS
    POLKANOV, VS
    GERASIMOVA, NM
    VINOGRADOV, AI
    GLAZKOVA, LK
    BOCHKARJOV, JM
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1992, 98 (04) : 607 - 607